An efficacy and safety study of intravenous pantoprazole in the prevention of recurrent peptic ulcer bleeding after successful hemostasis

Trial Profile

An efficacy and safety study of intravenous pantoprazole in the prevention of recurrent peptic ulcer bleeding after successful hemostasis

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2009

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Bleeding ulcer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top